Tenet Healthcare (THC) COO logs RSU grants, conversions and tax share disposals

Rhea-AI Filing Summary

Tenet Healthcare executive Lisa Y. Foo, EVP and Chief Operating Officer, reported several equity-related transactions in company stock. She received a grant of 7,520 restricted stock units dated 2026 February, which convert into common shares on a one-for-one basis. She also exercised 4,670 restricted stock units from a 2024 award and 4,199 units from a 2023 award, increasing her common stock holdings. To cover tax withholding obligations tied to vesting of performance and restricted stock units, 1,838 shares, 4,289 shares, and 13,706 shares of common stock were disposed of at reference prices of $237.58 and $239.39 per share, described as shares withheld for taxes rather than open-market sales. After these transactions, she directly owned 42,053 shares of Tenet Healthcare common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foo Lisa Y

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TX 75254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		M		4,670	A	(1)	57,687	D
Common Stock	02/27/2026		M		4,199	A	(1)	61,886	D
Common Stock	02/27/2026		F		1,838(2)	D	$237.58(3)	60,048	D
Common Stock	02/27/2026		F		4,289(4)	D	$239.39(5)	55,759	D
Common Stock	02/27/2026		F		13,706(2)	D	$239.39(5)	42,053	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2026 February Restricted Stock Units	(6)	02/27/2026		A		7,520		(6)	(6)	Common Stock	7,520	$0	7,520	D
2024 February Restricted Stock Units	(7)	02/27/2026		M			4,670	(7)	(7)	Common Stock(8)	4,670	$0	4,671	D
2023 March Restricted Stock Units	(9)	02/27/2026		M			4,199	(9)	(9)	Common Stock(8)	4,199	$0	0	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units.

3. Represents the closing price of the common stock of the Issuer on the vesting date for the award.

4. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

5. Represents the closing price of the common stock of the Issuer on February 27, 2026.

6. These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.

7. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend).

8. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

9. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend).

	Chad J. Wiener, as Attorney-in-fact for Lisa Y. Foo	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Tenet Healthcare (THC) report for Lisa Y. Foo?

Lisa Y. Foo reported grants, conversions, and tax-related disposals of Tenet Healthcare equity. She received 7,520 new restricted stock units, exercised prior awards into common stock, and had shares withheld to satisfy tax obligations tied to vesting, ending with 42,053 directly held common shares.

Did Lisa Y. Foo buy or sell Tenet Healthcare (THC) stock on the open market?

The reported transactions show equity grants, unit conversions, and shares withheld for taxes, not open-market trades. Dispositions coded "F" reflect shares delivered to cover exercise price or tax liabilities upon vesting of performance and restricted stock units, based on the issuer’s closing stock prices.

How many Tenet Healthcare (THC) restricted stock units were granted to Lisa Y. Foo?

Lisa Y. Foo received 7,520 restricted stock units labeled as 2026 February Restricted Stock Units. According to the disclosures, these time-based units convert into Tenet Healthcare common stock on a one-for-one basis and vest in scheduled increments under the company’s 2019 Stock Incentive Plan.

What were the tax-withholding stock dispositions for Tenet Healthcare (THC)?

Three tax-withholding dispositions were reported: 1,838 shares at $237.58 and 4,289 and 13,706 shares at $239.39. These shares were withheld or delivered to satisfy tax liabilities and exercise-related obligations when restricted and performance share units vested, rather than discretionary market sales.

What is Lisa Y. Foo’s Tenet Healthcare (THC) share ownership after these transactions?

Following the reported grants, conversions, and tax-related share withholdings, Lisa Y. Foo directly held 42,053 shares of Tenet Healthcare common stock. This figure reflects her remaining direct ownership after the equity awards vested and the related tax obligations were settled in shares.

How do Tenet Healthcare (THC) restricted stock units convert into common shares?

Tenet Healthcare restricted stock units convert into common stock on a one-for-one basis upon vesting. Time-based awards generally vest in one-third increments over three years and are then settled in shares of the company’s common stock, according to the described 2019 Stock Incentive Plan terms.